A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This trial is a single-arm study for patients presenting with both local and metastatic
adenocarcinoma of rectum. The aims of the trial are (1) to determine the tolerability rate,
and (2) to determine toxicity rates, pelvic and distant response rates in patients with
locally advanced rectal cancer in the presence of distant metastasis who are treated with an
interdigitating chemotherapy (oxaliplatin/5-fluorouracil [5FU]) and radiotherapy regimen.